Company: TELO
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-023970
Chunk: 43

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 8
Chunk 43
---
 basis and manages the Company’s operations as a whole for the purpose of evaluating financial
performance and allocating resources. Accordingly, the Company has determined that it has a single reportable and operating segment structure.
The CEO uses aggregate net loss to allocate resources in the annual budgeting and forecasting process and also uses that measure as a
basis for evaluating financial performance regularly by comparing actual results with established budgets and forecasts.

The
accounting policies of the Company’s single segment are the same as those described in the summary of significant accounting policies
within Note 1. The CEO assesses performance for the Company and decides how to allocate resources based on the aggregate net loss that
is also reported on the statement of operations as net loss. The measure of segment assets is reported on the balance sheets as total
assets.

The
table below provides information about the Company’s revenue, significant segment expenses and other segment expenses.

 Schedule
of Segment Information

    2025  
    2024 

    Three Months Ended June 30, 

    2025  
    2024 
  
    Revenues 
    $—  
    $— 
  
    Less segment expenses: 

    Research and development 
     42,839  
     594,801 
  
    Related party travel costs 
     -  
     - 
  
    General and administrative 
     5,028,158  
     879,695 
  
    Loss from operations 
    $5,070,997  
     1,474,496 
  
    Plus: 

    Interest income (expense),net 
     22  
     25,493 
  
    Segment net loss 
    $(5,070,975) 
    $(1,449,003)

    2025  
    2024 

    Six Months Ended June 30, 

    2025  
    2024 
  
    Revenues 
    $—  
    $— 
  
    Less segment expenses: 

    Research and development 
     379,835  
     1,398,824 
  
    Related party travel costs 
     -  
     370,500 
  
    General and administrative 
     6,877,857  
     1,621,237 
  
    Loss from operations 
    $7,257,692  
     3,390,561 
  
    Plus: